
Resources
You may find here a list of frequently asked questions about Cibinqo. Please consult your doctor for more details.
Frequently asked questions (FAQ)
In patients with mild renal impairment (eGFR 60 to <90 mL/min), no dose adjustment is required.1 If you have a moderate renal impairment (eGFR 30 to <60 mL/min), the recommended dose of Cibinqo is 100 mg or 50 mg once daily.1 In patients with severe renal impairment (eGFR <30 mL/min), the recommended starting dose is 50 mg once daily, with a maximum daily dose of 100 mg.1
eGFR, estimated glomerular filtration rate
- I have end-stage renal disease. Can I take Cibinqo?
Patient support programs
Cibinqo is subsidized by the Philanthropic Community Pharmacy of St. James' Settlement.
Contact the Philanthropic Community Pharmacy
(Reservations via phone is required)
Whatsapp: 5131 3638
Website: charityservices.sjs.org.hk
Wanchai Pharmacy
Tel: 2831 3289
Fax: 3104 3660
Address: North Wing, 8/F, St. James' Settlement, 85 Stone Nullah Lane, Wanchai (Wanchai MTR station Exit A3)
Sham Shui Po Pharmacy
Tel: 2389 9456
Fax: 3104 3621
Address: Shop No. 7, G/F, High One Grand, 188 Fuk Wing Street, Sham Shui Po, Kowloon (Cheung Sha Wan MTR station Exit A2)
Kwun Tong Pharmacy
Tel: 2116 4958
Fax: 3104 3684
Address: Shop C1, 12/F, TG Place, 10 Shing Yip Street, Kwun Tong, Kowloon (Kwun Tong MTR station Exit B1)
Fo Tan Pharmacy
Tel: 2116 1276
Fax: 3104 3601
Address: Room 917, 9/F, Shatin Galleria, 18-24 Shan Mei Street, Fo Tan, Shatin, New Territories (Fo Tan MTR station Exit B)
References
- CIBINQO® (abrocitinib) Prescribing Information. Pfizer Corporation Hong Kong Limited: Version January 2024.
- CIBINQO® (abrocitinib) Package Leaflet: Information for the patient. Pfizer Corporation Hong Kong Limited: Version January 2024.
- Jeziorkowska R, et al. Postepy Dermatol Alergol 2015;32:162-166.
- Traidl S, Werfel T. Allergologie select 2021;5:293-304.
- Staumont‐Sallé D, et al. JEADV Clin Pract 2023;2:518–530.
- Clark JD, et al. J Med Chem 2014;57:S023-S038.
- Guttman-Yassky E, et al. J Allergy Clin Immunol 2023;152:1394-1404.
- Bieber T, et al. N Engl J Med 2021;384:1101-1112.
- Vazquez ML, et al. J Med Chem 2018;61:1130-1152.